Q/C Technologies, Inc. Deferred Income Tax Expense (Benefit)
Q/C Technologies, Inc. (QCLS) reported Deferred Income Tax Expense (Benefit) of -$1.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-04-15
- Q/C Technologies, Inc. deferred income tax expense (benefit) for fiscal 2025 was -$1.61M.
- Q/C Technologies, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$5.45M, a 231.90% decline from fiscal 2023.
- Q/C Technologies, Inc. deferred income tax expense (benefit) for fiscal 2023 was $4.13M.
- Q/C Technologies, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$5.91M.
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$1.61M 10-K · filed 2026-04-15 | |
| 2024-12-31 | -$5.45M 10-K · filed 2026-04-15 | |
| 2023-12-31 | $4.13M 10-K · filed 2025-04-11 | |
| 2022-12-31 | -$5.91M 10-K · filed 2024-04-01 | |
| 2021-12-31 | -$6.22M 10-K · filed 2023-03-31 | |
| 2020-12-31 | -$1.96M 10-K · filed 2022-03-31 | |
| 2019-12-31 | -$738.00K 10-K · filed 2021-03-01 | |
| 2018-12-31 | -$2.94M 10-K · filed 2020-03-25 | |
| 2017-12-31 | -$6.00M 10-K · filed 2019-04-01 | -$6.44M 10-K · filed 2018-04-03 |
| 2016-12-31 | -$751.00K 10-K/A · filed 2018-07-13 | -$1.65M 10-K · filed 2017-04-11 |
| 2015-12-31 | $835.60K 10-K · filed 2017-04-11 | $3.80M 10-K · filed 2016-03-30 |
| 2014-12-31 | $132.38K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $203.66K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |